Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP471758.RAp5rNVnyJkQwuOo1Ji071x-fMP173wGl6qA9iMANQzZg130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471758.RAp5rNVnyJkQwuOo1Ji071x-fMP173wGl6qA9iMANQzZg130_provenance.
• NP625663.RAUmwvv-rmgMgJsutPYrdVU-KR506Zlo_dD0B8zG-J-0U130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625663.RAUmwvv-rmgMgJsutPYrdVU-KR506Zlo_dD0B8zG-J-0U130_provenance.
• NP547728.RAQmK5AgwnvpKURnrSThOsxk6OJkBZIrZbE3hOG7cs13c130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547728.RAQmK5AgwnvpKURnrSThOsxk6OJkBZIrZbE3hOG7cs13c130_provenance.
• NP547729.RASlrok1aEreSpeHs14etNa6xTAKSJ7AIMU7_ZG0Xy2DY130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547729.RASlrok1aEreSpeHs14etNa6xTAKSJ7AIMU7_ZG0Xy2DY130_provenance.
• NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
• NP547734.RAZKm74yhfwhwJKcVYRqM-od4zDwkgdIGQMvSuCjWVQKI130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547734.RAZKm74yhfwhwJKcVYRqM-od4zDwkgdIGQMvSuCjWVQKI130_provenance.
• NP547737.RAZsq5OKQs-HDSCNvJmJg0tHwdknTvzeIccvgwlP4WJDI130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547737.RAZsq5OKQs-HDSCNvJmJg0tHwdknTvzeIccvgwlP4WJDI130_provenance.
• NP547730.RABxQ6tBi-aa4hvhtkl4a_JDqlukvi9bqf4pW_DJDFRCA130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547730.RABxQ6tBi-aa4hvhtkl4a_JDqlukvi9bqf4pW_DJDFRCA130_provenance.
• NP622064.RArmL00V60L50pc1J81NDbvsW2ATJdts-d-ryyno_IWhQ130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622064.RArmL00V60L50pc1J81NDbvsW2ATJdts-d-ryyno_IWhQ130_provenance.
• NP623203.RAqaPPNFMqvV5JoyrZbSUPhlrQf5dCMnBGEd-3uE1b3gs130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623203.RAqaPPNFMqvV5JoyrZbSUPhlrQf5dCMnBGEd-3uE1b3gs130_provenance.
• NP624520.RAkYGG46QY1q2HOfXKZncJNhCg0futNFIWm1eIkXwG44w130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624520.RAkYGG46QY1q2HOfXKZncJNhCg0futNFIWm1eIkXwG44w130_provenance.
• NP547735.RAnGFivie4DYGUQzgIiAy3-gD64L0Yyid-xozrZvq0hk4130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547735.RAnGFivie4DYGUQzgIiAy3-gD64L0Yyid-xozrZvq0hk4130_provenance.
• NP412334.RAMRG5ovuALwplbcpb2Oe3d6WxywJnuNz8XvjRLW9btls130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412334.RAMRG5ovuALwplbcpb2Oe3d6WxywJnuNz8XvjRLW9btls130_provenance.
• NP547726.RAJrQMARbUVeOocjelaykmWmaYHOkff9Jnv3a2yGdrwDs130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547726.RAJrQMARbUVeOocjelaykmWmaYHOkff9Jnv3a2yGdrwDs130_provenance.
• NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_provenance.
• NP547739.RAMl0s1cYi_y28jJYGkYD1ECtf4AVGQBpyfiIQDLirMX4130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547739.RAMl0s1cYi_y28jJYGkYD1ECtf4AVGQBpyfiIQDLirMX4130_provenance.
• NP547727.RAzdsB6-dz7b6uRaNNMMly4BV0NRlvheJb-KgfN7xOzjc130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547727.RAzdsB6-dz7b6uRaNNMMly4BV0NRlvheJb-KgfN7xOzjc130_provenance.
• NP547731.RA_YL7NZSSctfaznehmUJBwf_WxhdT43GNA1CeNRQFC2g130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547731.RA_YL7NZSSctfaznehmUJBwf_WxhdT43GNA1CeNRQFC2g130_provenance.
• NP547736.RAxlzirWJrdC275FvXKosdSy4ZF1xv4eKTOlSCfTVop-8130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547736.RAxlzirWJrdC275FvXKosdSy4ZF1xv4eKTOlSCfTVop-8130_provenance.
• NP547738.RA89SFAZxztDief5JamACsjDqQ0Y4cm1E1rwbqX9GjMYo130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547738.RA89SFAZxztDief5JamACsjDqQ0Y4cm1E1rwbqX9GjMYo130_provenance.
• NP547740.RA9fD85ExSQ5Kw4zOaeCeBICyRaJDLHViMAQvNNXA9wfA130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547740.RA9fD85ExSQ5Kw4zOaeCeBICyRaJDLHViMAQvNNXA9wfA130_provenance.